Quest Diagnostics to offer FDA-cleared Roche pTau217 blood test
Quest Diagnostics says it will offer the FDA-cleared Roche pTau217 blood test to assess Alzheimer's disease pathology.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.